Bicon Pharmaceutical

Bicon Pharmaceutical manufactures and distributes pharmaceutical raw materials, patent medicines, chemicals, vaccines, and more.

Business Model: B2B

Revenue: $0

Employees: 1,001-5,000

Rankings

Detailed Bicon Pharmaceutical Information

Geographic Data

Bicon Pharmaceutical headquarters map

Address:

City: Xian

State: Hunan

Zip:

Country: China

Financial Info

Stage:

post ipo equity

Raised Last:

$250M

Raised Total:

$250M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Bicon Pharmaceutical is a large-scale pharmaceutical enterprise group with integrated businesses covering pharmaceutical raw materials, Chinese patent medicines, chemicals, biological agents, vaccine R&a;D, production and marketing. The production base of Bicon Pharmaceutical covers an area of 7.33 hectares and has the largest monomer workshop in Asia that meets the good manufacturing practice (GMP) standard. It has a sterilization space of 32,500 square meters and 15 production lines of tablets, capsules, soft capsules, granules, ointment, oral solution, syrup, large-volume injections, small-volume injections, and other products. The annual production capacity of the base is more than RMB 6 billion. The company also operates a herbal medicine extraction workshop of 5,000 square meters with an annual extraction capacity of 8,000 tons. Bicon Pharmaceutical was founded in 1997 and became a foreign-owned enterprise owned by Hong Kong Bicon International with a registered capital of RMB 937 million.

Contact Phone:

Contact Email:

Bicon Pharmaceutical went public on 5/25/2010 on the SZSE

Listed Exchange:
SZSE

IPO Date:
5/25/2010

Ticker Symbol:
002411

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2012 Post-IPO Equity 1 $250M PAG
PAG
11/2009 Series A 2 - Sequoia Capital
SIG China (SIG Asia Investments)
Sequoia Capital
SIG China (SIG Asia Investments)
11/2009 Series A 2 - Sequoia Capital
SIG China (SIG Asia Investments)
Sequoia Capital
SIG China (SIG Asia Investments)
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research